FDA
approval
· 2021-02-02
FDA Approved: CARBIDOPA AND LEVODOPA — Supplemental Application (Mylan Pharmaceuticals Inc.)
Summary
FDA approved a supplemental application for carbidopa and levodopa by Mylan Pharmaceuticals Inc., reflecting changes to an already approved product.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CARBIDOPA AND LEVODOPA (CARBIDOPA AND LEVODOPA)